Human embryonic stem cells and cardiac repair

Transplantation Reviews

Volumn 23, Issue 1, 2009, Pages 53-68

  Zhu, Wei Zhong ^a   Hauch, Kip D ^b   Xu, Chunhui ^c   Laflamme, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

^c GERON CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; ARTICLE; CALCIUM TRANSPORT; CARDIAC GRAFT REJECTION; CELL DIFFERENTIATION; CELL ISOLATION; CELL RENEWAL; CELL TRANSPORT; CELL ULTRASTRUCTURE; ELECTROPHYSIOLOGY; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENGRAFTMENT; GRAFT SURVIVAL; HEART CELL CULTURE; HEART DEVELOPMENT; HEART GRAFT; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PHENOTYPE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 56349150327     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2008.05.005     Document Type: Article

References (192)

1. Lloyd-Jones D.M. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep 3 (2001) 184-190
2. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
3. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
4. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
5. Laflamme M.A., Zbinden S., Epstein S.E., et al. Cell-based cardiac repair: pathophysiologic mechanisms. Ann Rev Pathol 2 (2007) 307-309
6. Rubart M., and Field L.J. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68 (2006) 29-49
7. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
8. Murry C.E., Wiseman R.W., Schwartz S.M., et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 (1996) 2512-2523
9. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4 (1998) 929-933
10. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
11. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73 (2002) 1919-1925 [discussion 1926]
12. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
13. Min J.Y., Sullivan M.F., Yang Y., et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 74 (2002) 1568-1575
14. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
15. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
16. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100 (2003) 12313-12318
17. Laugwitz K.L., Morretti A., Lam J., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
18. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
19. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
20. Leor J., Gerecht S., Cohen S., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93 (2007) 1278-1284
21. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50 (2007) 1884-1893
22. van Laake L.W., Passier R., Doevendans P.A., et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 1 (2007) 9-24
23. Tomescot A., Leschik J., Bellamy V., et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 25 (2007) 2200-2205
24. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
25. Menasche P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 50 (2007) 7-17
26. Schuleri K.H., Boyle A.J., and Hare J.M. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol (2007) 195-218
27. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
28. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
29. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
30. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
31. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 34 (2002) 241-249
32. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
33. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
34. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
35. Xu C., Police S., Rao N., et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
36. Mummery C., Ward-van O.D., Doevendans P., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
37. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
38. McDevitt T.C., Laflamme M.A., and Murry C.E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 39 (2005) 865-873
39. Snir M., Kehat I., Gepstein A., et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285 (2003) H2355-H2363
40. Laflamme M.A., Gold J., Xu C., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167 (2005) 663-671
41. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
42. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78 (1981) 7634-7638
43. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
44. Odorico J.S., Kaufman D.S., and Thomson J.A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19 (2001) 193-204
45. Xu C., Inokuma M.S., Denham J., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19 (2001) 971-974
46. Inzunza J., Gertow K., Stromberg M.A., et al. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 23 (2005) 544-549
47. Yoo S.J., Yoon B.S., Kim J.M., et al. Efficient culture system for human embryonic stem cells using autologous human embryonic stem cell-derived feeder cells. Exp Mol Med 37 (2005) 399-407
48. Xu C., Jiang J., Sottile V., et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22 (2004) 972-980
49. Xu R.-H., Peck R.M., Li D.S., et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 3 (2005) 185-190
50. Xu C., Rosler E., Jiang J., et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 23 (2005) 315-323
51. Ludwig T.E., Levenstein M.E., Jones J.M., et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24 (2006) 185-187
52. Li Y., Powell S., Brunette E., et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91 (2005) 688-698
53. Bongso A., and Tan S. Human blastocyst culture and derivation of embryonic stem cell lines. Stem Cell Rev 1 (2005) 87-98
54. Amit M., and Itskovitz-Eldor J. Sources, derivation, and culture of human embryonic stem cells. Semin Reprod Med 24 (2006) 298-303
55. Klimanskaya I., Chung Y., Becker S., et al. Derivation of human embryonic stem cells from single blastomeres. Nat Protoc 2 (2007) 1963-1972
56. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
57. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
58. Doetschman T.C., Eistetter H., Katz M., et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87 (1985) 27-45
59. Norstrom A., Akesson K., Hardarson T., et al. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med (Maywood) 231 (2006) 1753-1762
60. Lev S., Kehat I., and Gepstein L. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 1047 (2005) 50-65
61. Xu C., He J.Q., Kamp T.J., et al. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev 15 (2006) 931-941
62. He J.Q., Ma Y., Lee Y., et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 (2003) 32-39
63. Dai W., Field L.J., Rubart M., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 43 (2007) 504-516
64. Cui L., Johkura K., Takei S., et al. Structural differentiation, proliferation, and association of human embryonic stem cell-derived cardiomyocytes in vitro and in their extracardiac tissues. J Struct Biol 158 (2007) 307-317
65. Maltsev V.A., Rohwedel J., Hescheler J., et al. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44 (1993) 41-50
66. Sartiani L., Bettiol E., Stillitano F., et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25 (2007) 1136-1144
67. Satin J., Kehat I., Caspi O., et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 559 (2004) 479-496
68. Dolnikov K., Shilkrut M., Zeevi-Levin N., et al. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 1047 (2005) 66-75
69. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24 (2006) 236-245
70. Friedrich G., and Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5 (1991) 1513-1523
71. Weber K.T., and Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83 (1991) 1849-1865
72. Caspi O., Lesman A., Basevitch Y., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100 (2007) 263-272
73. Ferreira L.S., Gerecht S., Shieh H.F., et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res 101 (2007) 286-294
74. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99 (2002) 4391-4396
75. Huang H., Zhao X., Chen L., et al. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun 351 (2006) 321-327
76. Xie C.Q., Zhang J., Villacorta L., et al. A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol 27 (2007) e311-e312
77. Boheler K.R., Czyz J., Tweedie D., et al. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91 (2002) 189-201
78. Garry D.J., and Olson E.N. A common progenitor at the heart of development. Cell 127 (2006) 1101-1104
79. Kelly R.G., Brown N.A., and Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 1 (2001) 435-440
80. Cai C.L., Liang X., Shi Y., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5 (2003) 877-889
81. Kattman S.J., Huber T.L., and Keller G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11 (2006) 723-732
82. Moretti A., Caron L., Nakano A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006) 1151-1165
83. Wu S.M., Fujiwara Y., Cibulsky S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127 (2006) 1137-1150
84. Yatskievych T.A., Ladd A.N., and Antin P.B. Induction of cardiac myogenesis in avian pregastrula epiblast: the role of the hypoblast and activin. Development 124 (1997) 2561-2570
85. Fullilove S.L. Heart induction: distribution of active factors in newt endoderm. J Exp Zool 175 (1970) 323-326
86. Schultheiss T.M., Xydas S., and Lassar A.B. Induction of avian cardiac myogenesis by anterior endoderm. Development 121 (1995) 4203-4214
87. Sugi Y., and Lough J. Anterior endoderm is a specific effector of terminal cardiac myocyte differentiation of cells from the embryonic heart forming region. Dev Dyn 200 (1994) 155-162
88. Ladd A.N., Yatskievych T.A., and Antin P.B. Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins. Dev Biol 204 (1998) 407-419
89. Sugi Y., and Lough J. Activin-A and FGF-2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro. Dev Biol 168 (1995) 567-574
90. Schultheiss T.M., Burch J.B., and Lassar A.B. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11 (1997) 451-462
91. Schlange T., Andree B., Arnold H.H., et al. BMP2 is required for early heart development during a distinct time period. Mech Dev 91 (2000) 259-270
92. Yamashita J.K., Takano M., Hiraoka-Kinie M., et al. Prospective identification of cardiac progenitors by a novel single cell-based cardiomyocyte induction. Faseb J 19 (2005) 1534-1536
93. Monzen K., Shiojima I., Hiroi Y., et al. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol Cell Biol 19 (1999) 7096-7105
94. Monzen K., Hiroi Y., Kudoh S., et al. Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J Cell Biol 153 (2001) 687-698
95. Angello J.C., Kaestner S., Welikson R.E., et al. BMP induction of cardiogenesis in P19 cells requires prior cell-cell interaction(s). Dev Dyn 235 (2006) 2122-2133
96. Dono R., Scalera L., Pacifico F., et al. The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. Development 118 (1993) 1157-1168
97. Johnson S.E., Rothstein J.L., and Knowles B.B. Expression of epidermal growth factor family gene members in early mouse development. Dev Dyn 201 (1994) 216-226
98. Xu C., Liguori G., Persico M.G., et al. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development 126 (1999) 483-494
99. Xu C., Liguori G., Adamson E.D., et al. Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. Dev Biol 196 (1998) 237-247
100. Parisi S., D'Andrea D., Lago C.T., et al. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol 163 (2003) 303-314
101. Aoki T.O., David N.B., Minchiotti G., et al. Molecular integration of casanova in the Nodal signalling pathway controlling endoderm formation. Development 129 (2002) 275-286
102. Climent S., Sarasa M., Villar J.M., et al. Neurogenic cells inhibit the differentiation of cardiogenic cells. Dev Biol 171 (1995) 130-148
103. Antin P.B., Taylor R.G., and Yatskievych T. Precardiac mesoderm is specified during gastrulation in quail. Dev Dyn 200 (1994) 144-154
104. Schultheiss T.M., and Lassar A.B. Induction of chick cardiac myogenesis by bone morphogenetic proteins. Cold Spring Harb Symp Quant Biol 62 (1997) 413-419
105. Fishman M.C., and Chien K.R. Fashioning the vertebrate heart: earliest embryonic decisions. Development 124 (1997) 2099-2117
106. Tzahor E., and Lassar A.B. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev 15 (2001) 255-260
107. Marvin M.J., Di Rocco G., Gardiner A., et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 15 (2001) 316-327
108. Schneider V.A., and Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 15 (2001) 304-315
109. Nakamura T., Sano M., Songyang Z., et al. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 100 (2003) 5834-5839
110. Liu Y., Asakura M., Inoue H., et al. Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci U S A 104 (2007) 3859-3864
111. Ueno S., Weidinger G., Osugi T., et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A 104 (2007) 9685-9690
112. Naito A.T., Shiojima I., Akazawa H., et al. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A 103 (2006) 19812-19817
113. Pandur P., Lasche M., Eisenberg L.M., et al. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418 (2002) 636-641
114. Terami H., Hidaka K., Katsumata T., et al. Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem Biophys Res Commun 325 (2004) 968-975
115. Antin P.B., Yatskievych T., Dominguez J.L., et al. Regulation of avian precardiac mesoderm development by insulin and insulin-like growth factors. J Cell Physiol 168 (1996) 42-50
116. Zhu X., Sasse J., McAllister D., et al. Evidence that fibroblast growth factors 1 and 4 participate in regulation of cardiogenesis. Dev Dyn 207 (1996) 429-438
117. Kawai T., Takahashi T., Esaki M., et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 68 (2004) 691-702
118. Sachinidis A., Gissel C., Nierhoff D., et al. Identification of platelet-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem 13 (2003) 423-429
119. Wu H., Lee S.H., Gao J., et al. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126 (1999) 3597-3605
120. Jankowski M., Hajjar F., Kawas S.A., et al. Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A 95 (1998) 14558-14563
121. Paquin J., Danalache B.A., Jankowski M., et al. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A 99 (2002) 9550-9555
122. Matsuura K., Nagai T., Nishigaki N., et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279 (2004) 11384-11391
123. Danalache B.A., Paquin J., Donghao W., et al. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 25 (2007) 679-688
124. Rones M.S., McLaughlin K.A., Raffin M., et al. Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis. Development 127 (2000) 3865-3876
125. Chau M.D., Tuft R., Fogarty K., et al. Notch signaling plays a key role in cardiac cell differentiation. Mech Dev 123 (2006) 626-640
126. Nemir M., Croquelois A., Pedrazzini T., et al. Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling. Circ Res 98 (2006) 1471-1478
127. Lowell S., Benchoua A., Heavey B., et al. Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol 4 (2006) e121
128. Passier R., Oostwaard D.W., Snapper J., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23 (2005) 772-780
129. Takahashi T., Lord B., Schulze P.C., et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107 (2003) 1912-1916
130. Burridge P.W., Anderson D., Priddle H., et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 25 (2007) 929-938
131. Shim W.S., Jiang S., Wong P., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324 (2004) 481-488
132. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs 25 (2001) 187-193
133. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
134. Rangappa S., Fen C., Lee E.H., et al. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75 (2003) 775-779
135. Choi S.C., Yoon J., Shim W.J., et al. 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36 (2004) 515-523
136. Yoon B.S., Yoo S.J., Lee J.E., et al. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 74 (2006) 149-159
137. Edwards M.K., Harris J.F., and McBurney M.W. Induced muscle differentiation in an embryonal carcinoma cell line. Mol Cell Biol 3 (1983) 2280-2286
138. Wobus A.M., Kaomei G., Shan J., et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 29 (1997) 1525-1539
139. Mummery C., Ward D., van den Brink C.E., et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200 (2002) 233-242
140. Reubinoff B.E., Pera M.F., Fong C.Y., et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18 (2000) 399-404
141. Klug M.G., Soonpaa M.H., Koh G.Y., et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98 (1996) 216-224
142. Zandstra P.W., Bauwens C., Yin T., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9 (2003) 767-778
143. Zweigerdt R., Burg M., Willbold E., et al. Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. Cytotherapy 5 (2003) 399-413
144. Muller M., Fleischmann B.K., Selbert S., et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. Faseb J 14 (2000) 2540-2548
145. Anderson D., Self T., Mellor I.R., et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 15 (2007) 2027-2036
146. Huber I., Itzhaki I., Caspi O., et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. Faseb J 21 (2007) 2551-2563
147. Xu C., Police S., Hassanipour M., et al. Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev 15 (2006) 631-639
148. Soonpaa M.H., et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264 (1994) 98-101
149. Koh G.Y., Soonpaa M.H., Klug M.G., et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96 (1995) 2034-2042
150. Leor J., Patterson M., Quinones M.J., et al. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium. Circulation 94 9 Suppl (1996) II332-II336
151. Li R.K., Jia Z.Q., Weisel R.D., et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62 (1996) 654-660 discussion 660-1
152. Scorsin M., Hagege A.A., Marotte F., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium. Circulation 96 9 Suppl (1997) II-188-II-193
153. Etzion S., Battler A., Barbash I.M., et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 33 (2001) 1321-1330
154. Reinecke H., Zhang M., Bartosek T., et al. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100 (1999) 193-202
155. Min J.Y., Yang Y., Converso K.L., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92 (2002) 288-296
156. Min J.Y., Yang Y., Sullivan M.F., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125 (2003) 361-369
157. Kolossov E., Bostani T., Roell W., et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203 (2006) 2315-2327
158. Naito H., Nishizaki K., Yoshikawa M., et al. Xenogeneic embryonic stem cell-derived cardiomyocyte transplantation. Transplant Proc 36 (2004) 2507-2508
159. Menard C., Hagege A.A., Agbulut O., et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366 (2005) 1005-1012
160. Hodgson D.M., Behfar A., Zingman L.V., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
161. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. Faseb J 16 (2002) 1558-1566
162. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J 21 (2007) 1345-1357
163. Swijnenburg R.J., Tanaka M., Vogel H., et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112 9 Suppl (2005) I166-I172
164. Kehat I., Khimovich L., Caspi O., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22 (2004) 1282-1289
165. Xue T., Cho H.C., Akar F.G., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
166. Kofidis T., Lebl D.R., Swijnenburg R.J., et al. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 29 (2006) 50-55
167. Xie C.Q., Zhang J., Xiao Y., et al. Transplantation of human undifferentiated embryonic stem cells into a myocardial infarction rat model. Stem Cells Dev 16 (2007) 25-29
168. Leobon B., Garcin I., Menasche P., et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100 (2003) 7808-7811
169. Halbach M., Pfannkuche K., Pillekamp F., et al. Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res 101 (2007) 484-492
170. Rubart M., Pasumarthi K.B., Nakajima H., et al. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 92 (2003) 1217-1224
171. Rubart M., Soonpaa M.H., Nakajima H., et al. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114 (2004) 775-783
172. Drukker M., Katchman H., Katz G., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24 (2006) 221-229
173. van den Brandt J., Kovacs P., and Kloting I. Blood pressure, heart rate and motor activity in 6 inbred rat strains and wild rats (Rattus norvegicus): a comparative study. Exp Anim 48 (1999) 235-240
174. Thompson C.A., Reddy V.K., Srinivasan A., et al. Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells. J Heart Lung Transplant 24 (2005) 1385-1392
175. Oron U., Halevy O., Yaakobi T., et al. Technical delivery of myogenic cells through an endocardial injection catheter for myocardial cell implantation. Int J Cardiovasc Intervent 3 (2000) 227-230
176. Wang C.C., Chen C.H., Lin W.W., et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 77 (2008) 515-524
177. Zhang M., Methot D., Poppa V., et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
178. Muller-Ehmsen J., Whittaker P., Kloner R.A., et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34 (2002) 107-116
179. Fox K.A., Steg P.G., Eagle K.A., et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 297 (2007) 1892-1900
180. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
181. Jawad H., Ali N.N., Lyon A.R., et al. Myocardial tissue engineering: a review. J Tissue Eng Regen Med 1 (2007) 327-342
182. Zimmermann W.H., and Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 17 (2007) 134-140
183. Alperin C., Zandstra P.W., and Woodhouse K.A. Engineering cardiac healing using embryonic stem cell-derived cardiac cell seeded constructs. Front Biosci 12 (2007) 3694-3712
184. Levenberg S., Zoldan J., Basevitch Y., et al. Endothelial potential of human embryonic stem cells. Blood 110 (2007) 806-814
185. Davis M.E., et al. Custom design of the cardiac microenvironment with biomaterials. Circ Res 97 (2005) 8-15
186. Chen C.H., Chang Y., Wang C.C., et al. Construction and characterization of fragmented mesenchymal-stem-cell sheets for intramuscular injection. Biomaterials 28 (2007) 4643-4651
187. Blan N.R., and Birla R.K. Design and fabrication of heart muscle using scaffold-based tissue engineering. J Biomed Mater Res A 86 (2008) 195-208
188. Franchini J.L., Propst J.T., Comer G.R., et al. Novel tissue engineered tubular heart tissue for in vitro pharmaceutical toxicity testing. Microsc Microanal 13 (2007) 267-271
189. Masuda S., Shimizu T., Yamato M., et al. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 60 (2008) 277-285
190. Radisic M., Park H., Gerecht S., et al. Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci 362 (2007) 1357-1368
191. Radisic M., Park H., Martens T.P., et al. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A 86A (2007) 713-724 [Epub ahead of print]
192. Yildirim Y., Naito H., Didie M., et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 116 11 Suppl (2007) I16-I23